These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 20553815)

  • 21. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons.
    Melis M; Perra S; Muntoni AL; Pillolla G; Lutz B; Marsicano G; Di Marzo V; Gessa GL; Pistis M
    J Neurosci; 2004 Nov; 24(47):10707-15. PubMed ID: 15564588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.
    Adermark L; Lovinger DM
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20564-9. PubMed ID: 18077376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabotropic P2Y purinoceptor-mediated presynaptic and postsynaptic enhancement of cerebellar GABAergic transmission.
    Saitow F; Murakoshi T; Suzuki H; Konishi S
    J Neurosci; 2005 Feb; 25(8):2108-16. PubMed ID: 15728851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exogenous and endogenous cannabinoids suppress inhibitory neurotransmission in the human neocortex.
    Kovacs FE; Knop T; Urbanski MJ; Freiman I; Freiman TM; Feuerstein TJ; Zentner J; Szabo B
    Neuropsychopharmacology; 2012 Apr; 37(5):1104-14. PubMed ID: 22048459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus.
    Neu A; Földy C; Soltesz I
    J Physiol; 2007 Jan; 578(Pt 1):233-47. PubMed ID: 17053036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons.
    Talani G; Lovinger DM
    Alcohol; 2015 Dec; 49(8):781-94. PubMed ID: 26603632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.
    Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y
    Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabotropic suppression of excitation in murine autaptic hippocampal neurons.
    Straiker A; Mackie K
    J Physiol; 2007 Feb; 578(Pt 3):773-85. PubMed ID: 17110416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
    Hampson RE; Miller F; Palchik G; Deadwyler SA
    Neuropharmacology; 2011 May; 60(6):944-52. PubMed ID: 21288475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.
    Mitchell VA; Kawahara H; Vaughan CW
    J Physiol; 2009 Jun; 587(Pt 11):2511-20. PubMed ID: 19359367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.
    Ohno-Shosaku T; Hashimotodani Y; Ano M; Takeda S; Tsubokawa H; Kano M
    J Physiol; 2007 Oct; 584(Pt 2):407-18. PubMed ID: 17615096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex.
    Yoshino H; Miyamae T; Hansen G; Zambrowicz B; Flynn M; Pedicord D; Blat Y; Westphal RS; Zaczek R; Lewis DA; Gonzalez-Burgos G
    J Physiol; 2011 Oct; 589(Pt 20):4857-84. PubMed ID: 21807615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta.
    Freestone PS; Guatteo E; Piscitelli F; di Marzo V; Lipski J; Mercuri NB
    Neuropharmacology; 2014 Apr; 79():467-75. PubMed ID: 24334069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice.
    Kortleven C; Fasano C; Thibault D; Lacaille JC; Trudeau LE
    Eur J Neurosci; 2011 May; 33(10):1751-60. PubMed ID: 21410793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids.
    Diana MA; Levenes C; Mackie K; Marty A
    J Neurosci; 2002 Jan; 22(1):200-8. PubMed ID: 11756503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons.
    Fortin DA; Levine ES
    Cereb Cortex; 2007 Jan; 17(1):163-74. PubMed ID: 16467564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glial glutamate transporters limit spillover activation of presynaptic NMDA receptors and influence synaptic inhibition of Purkinje neurons.
    Huang H; Bordey A
    J Neurosci; 2004 Jun; 24(25):5659-69. PubMed ID: 15215288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the effects of cannabinoids on identified synaptic connections in the caudate-putamen by paired recordings in transgenic mice.
    Freiman I; Anton A; Monyer H; Urbanski MJ; Szabo B
    J Physiol; 2006 Sep; 575(Pt 3):789-806. PubMed ID: 16825300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala.
    Zhu PJ; Lovinger DM
    J Neurosci; 2005 Jun; 25(26):6199-207. PubMed ID: 15987949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.
    Fukudome Y; Ohno-Shosaku T; Matsui M; Omori Y; Fukaya M; Tsubokawa H; Taketo MM; Watanabe M; Manabe T; Kano M
    Eur J Neurosci; 2004 May; 19(10):2682-92. PubMed ID: 15147302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.